PBYI Puma Biotechnology Inc - Common Stock
$8.81
株価 · 8月 18, 2026
ファンダメンタルズ（時点） 8月 6, 2026
Puma Biotechnology Inc - Common Stock について Wikipediaからの企業概要
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
続きを読む
Puma Biotechnology is a publicly traded biopharmaceutical company (NASDAQ: PBYI) headquartered in Los Angeles, CA.
Creation
Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. This was the same business plan Auerbach had followed at Cougar Biotechnology, which he founded in 2003, and through which he in-licensed abiraterone acetate from BTG plc. Cougar further developed abiraterone before the company was sold to Johnson & Johnson in 2009. Auerbach brought many Cougar employees with him after founding Puma in 2010.
Funding for development
In August 2011 Puma licensed two drug candidates from Pfizer: neratinib (PB272) and an analog (PB357) to serve as a backup candidate.
As part of an approximately $60 million financing round in October 2011, Puma entered into a reverse merger with the shell company Innovative Acquisitions Corp., formed in 2007. In April 2012 the company's stock began trading over the counter. In October 2012 the company raised around $138 million and its shares were listed on the New York Stock Exchange.
In 2016 Puma discovered that Robert Gadimian, senior director of regulatory affairs, had twice bought and sold stock based on his knowledge of unpublished clinical trial results; Puma quickly fired him after conducting an internal investigation and reported the insider trading to the SEC.
Approval and licensing of neratinib
In March 2016 Puma held a pre-NDA meeting with the FDA in which the FDA raised concerns about the design and conduct of clinical trials that Puma had run and recommended that Puma not file the NDA with that data.
Puma did file the NDA, and in May 2017 an FDA review panel recommended that the FDA approve neratinib but raised concerns that the intended use was too broad and should be limited to people with specific mutations. The FDA's briefing document to the panel had raised concerns about the marginal benefit of the drug and the side effects. In July 2017 the FDA approved neratinib for use in preventing the return of breast cancer after treatment that included trastuzumab and without any need for genetic testing, and with warnings about the risk of severe diarrhea. U.S. sales of neratinib totaled $200.5 million in 2018.
In January 2018 an EMA committee gave a negative review to neratinib. In June 2018 this same EMA committee recommended the approval of neratinib, which received European Commission (EC) approval in September 2018.
In 2019 Puma licensed commercialization rights in Europe and part of Africa to Pierre Fabre for an upfront payment of $60 million and milestone payments that could reach $345 million. Previously, Puma licensed rights in Greater China to CANbrdige Life Sciences, rights in Israel to Medison Pharma, rights in Canada to Knight Therapeutics, rights in South East Asian to Specialised Therapeutics and rights in Latin America to Pint Pharma.
== References ==
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
PBYI 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$8.81
時価総額
$448M
P/E (TTM)
14.6
EPS（TTM）
$0.61
収益（TTM）
$228M
配当利回り
—
ROE
26.5%
負債/自己資本
0.2
52週レンジ
$4 – $9
PBYI 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
Configure
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益と純利益
$228M
2017-12-31
→
2025-12-31
EPS
$0.61
2020-12-31
→
2025-12-31
フリーキャッシュフロー
$42M
2016-12-31
→
2025-12-31
利益率
13.6%
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
指標
5年トレンド
PBYI
競合中央値
P/E (TTM)
14.6
17.4
P/S (TTM) (株価売上高倍率（TTM）)
2.0
52.3
P/B (株価純資産倍率)
3.4
4.8
EV / EBITDA (EV/EBITDA)
10.0
—
Price / FCF (株価FCF倍率)
10.7
—
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
指標
5年トレンド
PBYI
競合中央値
Operating Margin (営業利益率)
16.3%
—
Net Profit Margin (純利益率)
13.6%
-670.1%
ROA
14.5%
-41.1%
ROE
26.5%
-52.6%
ROIC
21.2%
—
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
指標
5年トレンド
PBYI
競合中央値
Debt / Equity (負債資本倍率)
0.2
—
Current Ratio (流動比率)
2.0
7.7
Quick Ratio (クイックレシオ)
1.9
—
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
指標
5年トレンド
PBYI
競合中央値
Revenue YoY (収益（前年比）)
-0.91%
—
Revenue CAGR 3Y (収益（3年CAGR）)
0.05%
—
Revenue CAGR 5Y (収益（5年CAGR）)
0.29%
—
EPS YoY
-1.6%
—
Net Income YoY (純利益（前年比）)
2.8%
—
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
指標
5年トレンド
PBYI
競合中央値
PBYI アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
売り
6 アナリスト
- 強い買い 0 0.0%
- 買い 0 0.0%
- 保有 3 50.0%
- 売り 1 16.7%
- 強い売り 2 33.3%
12ヶ月目標株価
1 アナリスト · 2026-08-18
安値
$6.00
高値
$6.00
中央値ターゲット
$6.00
-31.9%
平均値ターゲット
$6.00
-31.9%
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
0.07%
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $0.16 | $0.04 | 0.12% |
| 2026年3月31日 | $-0.07 | $-0.13 | 0.06% |
| 2025年12月31日 | $0.26 | $0.23 | 0.03% |
| 2025年9月30日 | $0.17 | $0.05 | 0.12% |
| 2025年6月30日 | $0.12 | $0.10 | 0.02% |
| 2025年3月31日 | $0.06 | $-0.02 | 0.08% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| CMPX | $958M | — | — | — | -45.9% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 17
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $228M | $230M | $236M | $228M | $253M | $225M | $272M | $251M | $28M | |
| Cost of Revenue | $58M | $64M | $63M | $55M | $64M | $39M | $37M | $35M | $6M | |
| R&D Expense | · | · | · | · | $72M | $98M | $133M | $165M | $208M | |
| SG&A Expense | $71M | $80M | $90M | $90M | $116M | $118M | $142M | $146M | $107M | |
| Operating Expenses | $191M | $200M | $203M | $204M | $252M | $256M | $311M | $346M | $320M | |
| Operating Income | $37M | $31M | $33M | $24M | $1M | $-30M | $-39M | $-95M | $-292M | |
| Interest Expense | · | · | $13M | $12M | $13M | $14M | $15M | $11M | $720.0K | |
| Interest Income | $4M | $5M | $3M | $813.0K | $160.0K | $489.0K | $3M | $2M | $1M | |
| Other Non-op | $1M | $862.0K | $759.0K | $-28.0K | $292.0K | $367.0K | $128.0K | $-714.0K | $-101.0K | |
| Pretax Income | $36M | $24M | $23M | $457.0K | $-29M | $-60M | $-76M | $-114M | · | |
| Income Tax | $5M | $-6M | $1M | $455.0K | $324.0K | $207.0K | $53.0K | $17.0K | $0 | |
| Net Income | $31M | $30M | $22M | $2.0K | $-29M | $-60M | $-76M | $-114M | $-292M | |
| EPS (Basic) | $0.62 | $0.62 | $0.46 | $0.00 | $-0.72 | $-1.52 | $-75595.00 | · | · | |
| EPS (Diluted) | $0.61 | $0.62 | $0.45 | $0.00 | $-0.72 | $-1.52 | · | · | · | |
| Shares (Basic) | 50,011,485 | 48,648,701 | 47,134,331 | 44,674,501 | 40,638,852 | 39,576,107 | · | · | · | |
| Shares (Diluted) | 50,653,283 | 49,100,433 | 47,550,852 | 44,929,998 | 40,638,852 | 39,576,107 | · | · | · | |
| EBITDA | $37M | $31M | $33M | $24M | $1M | $-30M | $-39M | $-95M | $-292M |
貸借対照表 26
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $69M | $85M | $76M | $63M | $85M | $60M | $108M | $82M | |
| Short-term Investments | $68M | $32M | $11M | $5M | $19M | $8M | $52M | $57M | · | |
| Receivables | $54M | $32M | $48M | $40M | $33M | $26M | $29M | $21M | $10M | |
| Inventory | $6M | $9M | $7M | $5M | $7M | $3M | $3M | $3M | $2M | |
| Prepaid Expense | $4M | $6M | $4M | $6M | $9M | $11M | $13M | $12M | $13M | |
| Other Current Assets | $256.0K | $91.0K | $912.0K | $2M | $447.0K | $4M | $323.0K | $2M | · | |
| Current Assets | $163M | $148M | $156M | $134M | $140M | $146M | $166M | $203M | $106M | |
| PP&E (Net) | $187.0K | $515.0K | $855.0K | $1M | $2M | $2M | $3M | $4M | $4M | |
| PP&E (Gross) | $5M | $8M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Accum. Depreciation | $5M | $8M | $8M | $7M | $7M | $6M | $6M | $5M | $4M | |
| Intangibles | $41M | $51M | $61M | $71M | $66M | $74M | $40M | $44M | $48M | |
| Total Assets | $216M | $213M | $231M | $222M | $227M | $244M | $235M | $259M | $166M | |
| Accounts Payable | $5M | $6M | $7M | $6M | $11M | $12M | $19M | $21M | $28M | |
| Accrued Liabilities | $50M | $37M | $53M | $53M | $93M | $61M | $69M | $46M | $31M | |
| Current Liabilities | $81M | $96M | $99M | $77M | $110M | $114M | $91M | $67M | $58M | |
| Capital Leases | $5M | $1M | $7M | $12M | $16M | $20M | $23M | · | · | |
| Other Non-current Liabilities | $0 | $121.0K | $121.0K | · | · | · | · | · | · | |
| Total Liabilities | $86M | $121M | $177M | $200M | $229M | $250M | $217M | $225M | $112M | |
| Long-term Debt | $23M | $68M | $102M | $102M | $102M | $84M | $95M | $152M | $48M | |
| Total Debt | $23M | $67M | $100M | $98M | $97M | $98M | · | · | · | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-1.28B | $-1.31B | $-1.35B | $-1.37B | $-1.37B | $-1.34B | $-1.28B | $-1.20B | $-1.09B | |
| AOCI | $36.0K | $6.0K | $-4.0K | $0 | $-2.0K | $0 | $62.0K | $-12.0K | · | |
| Stockholders' Equity | $130M | $92M | $53M | $22M | $-2M | $-6M | $17M | $34M | $53M | |
| Liabilities + Equity | $216M | $213M | $231M | $222M | $227M | $244M | $235M | $259M | $166M | |
| Shares Outstanding | 50,408,023 | 49,105,834 | 47,646,787 | 46,345,660 | 41,175,507 | 40,086,387 | 39,203,304 | 38,325,037 | 37,594,851 |
キャッシュフロー 14
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $11M | $12M | $12M | $10M | $11M | $10M | $8M | $7M | $3M | |
| Stock-based Comp | $7M | $8M | $10M | $12M | $33M | $37M | $57M | $87M | $109M | |
| Deferred Tax | $3M | $-7M | $0 | $0 | · | · | · | · | · | |
| Amort. of Intangibles | $10M | $10M | $8M | $8M | $8M | $6M | $4M | $4M | $2M | |
| Operating Cash Flow | $42M | $39M | $27M | $-16M | $21M | $773.0K | $22M | $-24M | $-172M | |
| CapEx | $71.0K | $56.0K | $140.0K | $0 | $0 | $46.0K | $306.0K | $439.0K | $431.0K | |
| Investing Cash Flow | $-36M | $-20M | $-19M | $7M | $-11M | $33M | $5M | $-58M | $-15M | |
| Debt Issued | · | · | · | · | · | · | $25M | $105M | $50M | |
| Net Debt Issued | · | · | · | · | · | · | $25M | $105M | $50M | |
| Financing Cash Flow | $-45M | $-34M | $0 | $12M | $-32M | $-10M | $-67M | $108M | $75M | |
| Net Change in Cash | $-40M | $-15M | $8M | $4M | $-22M | $24M | $-40M | $27M | $-113M | |
| Taxes Paid | $1M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $42M | $39M | $27M | $-16M | $21M | · | · | $-25M | $-173M | |
| Levered FCF | · | · | $14M | $-16M | $8M | · | · | · | · |
収益性 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% | -13.5% | -14.4% | -37.7% | -1056.1% | |
| Net Margin | 13.6% | 13.1% | 9.2% | 0.00% | -11.5% | -26.7% | -27.8% | -45.2% | -1054.6% | |
| Pretax Margin | 15.7% | 10.5% | 9.6% | 0.20% | -11.4% | -26.6% | · | · | · | |
| EBITDA Margin | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% | -13.5% | -14.4% | -37.7% | -1056.1% | |
| ROA | 14.5% | 13.6% | 9.5% | 0.00% | -12.4% | -25.0% | -30.6% | -53.5% | -139.6% | |
| ROE | 26.5% | 37.1% | 46.8% | 0.01% | 435.8% | 1873.7% | -436.4% | -283.2% | -221.9% | |
| ROIC | 21.2% | 24.4% | 20.3% | 0.09% | 1.4% | -33.0% | · | · | · |
流動性と支払能力 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.5 | 1.6 | 1.7 | 1.3 | 1.3 | 1.8 | 3.0 | 1.8 | |
| Quick Ratio | 1.9 | 1.4 | 1.4 | 1.6 | 1.0 | 1.0 | 1.5 | 2.8 | 1.6 | |
| Debt / Equity | 0.2 | 0.7 | 1.9 | 4.5 | -39.7 | -16.5 | · | · | · | |
| LT Debt / Equity | 0.0 | 0.2 | 1.2 | 4.5 | -39.7 | -14.1 | · | · | · | |
| Interest Coverage | · | · | 2.4 | 2.0 | 0.1 | -2.2 | -2.6 | -8.6 | -406.1 |
効率性 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.0 | 1.0 | 1.1 | 0.9 | 1.1 | 1.2 | 0.1 | |
| Inventory Turnover | 8.2 | 8.2 | 10.8 | 9.5 | 12.1 | · | · | 14.9 | 5.5 | |
| Receivables Turnover | 5.3 | 5.8 | 5.3 | 6.3 | 8.7 | 8.3 | 11.0 | 16.5 | 5.7 |
成長率 6
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.91% | -2.2% | 3.3% | -9.9% | 12.5% | · | · | · | · | |
| Revenue CAGR 3Y | 0.05% | -3.1% | 1.5% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.29% | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.6% | 37.8% | · | · | · | · | · | · | · | |
| Net Income YoY | 2.8% | 40.2% | 1079450.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 2396.3% | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 14
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $228M | $230M | $236M | $228M | $253M | $225M | $272M | $251M | $28M | |
| Net Income TTM | $31M | $30M | $22M | $2.0K | $-29M | $-60M | $-76M | $-114M | $-292M | |
| Market Cap | $300M | $150M | $206M | $174M | $122M | $411M | $343M | $780M | $3.72B | |
| Enterprise Value | $225M | $116M | $210M | $191M | $137M | $416M | · | · | · | |
| P/E | 9.8 | 4.9 | 9.6 | · | -4.2 | -6.8 | · | · | · | |
| P/S | 1.3 | 0.6 | 0.9 | 0.8 | 0.5 | 1.8 | 1.3 | 3.1 | 134.2 | |
| P/B | 2.3 | 1.6 | 3.9 | 8.1 | -49.8 | -69.1 | 19.6 | 22.7 | 69.7 | |
| P / Tangible Book | 3.4 | 3.7 | · | · | · | · | · | · | · | |
| P / Cash Flow | 7.2 | 3.8 | 7.6 | -11.0 | 5.9 | 532.1 | 15.3 | -32.4 | -21.5 | |
| P / FCF | 7.2 | 3.9 | 7.7 | -11.0 | 5.9 | · | · | -31.8 | -21.5 | |
| EV / EBITDA | 6.0 | 3.7 | 6.4 | 8.1 | 106.1 | -13.7 | · | · | · | |
| EV / FCF | 5.4 | 3.0 | 7.8 | -12.1 | 6.6 | · | · | · | · | |
| EV / Revenue | 1.0 | 0.5 | 0.9 | 0.8 | 0.5 | 1.8 | · | · | · | |
| Earnings Yield | 10.2% | 20.3% | 10.4% | 0.00% | -23.7% | -14.8% | · | · | · |
損益計算書 16
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57M | $45M | $75M | $54M | $52M | $46M | $59M | $81M | $47M | $44M | $72M | $56M | $55M | $53M | $66M | $57M | |
| Cost of Revenue | $12M | $10M | $23M | $12M | $12M | $11M | $14M | $29M | $11M | $11M | $24M | $13M | $12M | $13M | $17M | $12M | |
| SG&A Expense | $18M | $18M | $18M | $17M | $18M | $18M | $17M | $17M | $25M | $22M | $20M | $23M | $24M | $22M | $25M | $24M | |
| Operating Expenses | $49M | $49M | $58M | $45M | $46M | $42M | $46M | $58M | $49M | $46M | $57M | $48M | $50M | $48M | $56M | $55M | |
| Operating Income | $8M | $-4M | $17M | $10M | $7M | $4M | $13M | $22M | $-2M | $-2M | $15M | $9M | $5M | $4M | $10M | $2M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $3M | $3M | · | $3M | |
| Interest Income | $831.0K | $1M | $977.0K | $1M | $956.0K | $1M | $1M | $1M | $1M | $972.0K | $719.0K | $689.0K | $660.0K | $537.0K | $519.0K | $216.0K | |
| Other Non-op | $9.0K | $130.0K | $143.0K | $115.0K | $410.0K | $359.0K | $268.0K | $347.0K | $156.0K | $91.0K | $641.0K | $74.0K | $86.0K | $-42.0K | $-204.0K | $64.0K | |
| Pretax Income | $8M | $-3M | $17M | $9M | $6M | $3M | $12M | $21M | $-4M | $-5M | $13M | $6M | $2M | $2M | $-5M | $-293.0K | |
| Income Tax | · | · | · | · | · | · | $-7M | $291.0K | $378.0K | $220.0K | $536.0K | $213.0K | $187.0K | $147.0K | $294.0K | $67.0K | |
| Net Income | $8M | $-4M | $13M | $9M | $6M | $3M | $19M | $20M | $-5M | $-5M | $12M | $6M | $2M | $1M | $-6M | $-360.0K | |
| EPS (Basic) | $0.16 | $-0.07 | $0.26 | $0.18 | $0.12 | $0.06 | $0.40 | $0.41 | $-0.09 | $-0.10 | $0.26 | $0.12 | $0.05 | $0.03 | $-0.12 | $-0.01 | |
| EPS (Diluted) | $0.16 | $-0.07 | $0.26 | $0.17 | $0.12 | $0.06 | $0.40 | $0.41 | $-0.09 | $-0.10 | $0.25 | $0.12 | $0.05 | $0.03 | $-0.12 | $-0.01 | |
| Shares (Basic) | 50,939,946 | 50,845,130 | -99,623,885 | 50,339,456 | 49,700,217 | 49,595,697 | -96,841,433 | 49,008,464 | 48,292,414 | 48,189,256 | -93,781,152 | 47,520,338 | 46,759,062 | 46,636,083 | -88,159,871 | 45,567,739 | |
| Shares (Diluted) | 52,596,589 | 50,845,130 | -100,327,655 | 50,929,893 | 50,144,704 | 49,906,341 | -96,554,598 | 49,173,361 | 48,292,414 | 48,189,256 | -94,627,471 | 47,819,234 | 47,201,185 | 47,157,904 | -88,204,189 | 45,567,739 | |
| EBITDA | $8M | $-4M | · | $10M | $7M | · | · | $22M | $-2M | $-2M | · | $9M | $5M | $4M | · | $2M |
貸借対照表 26
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $36M | $30M | $54M | $55M | $63M | $69M | $67M | $67M | $77M | · | $82M | $60M | $61M | · | $78M | |
| Short-term Investments | $57M | $65M | $68M | $41M | $41M | $30M | $32M | $29M | $30M | $30M | · | $3M | $14M | $10M | · | $0 | |
| Receivables | $34M | $26M | $54M | $34M | $26M | $25M | $32M | $55M | $28M | $25M | · | $29M | $31M | $31M | · | $28M | |
| Inventory | $13M | $9M | $6M | $9M | $9M | $9M | $9M | $3M | $9M | $7M | · | $6M | $8M | $4M | · | $5M | |
| Prepaid Expense | $4M | $3M | $4M | $4M | $4M | $5M | $6M | $3M | $3M | $4M | · | $4M | $5M | $5M | · | $7M | |
| Other Current Assets | $199.0K | $196.0K | $256.0K | $230.0K | $73.0K | $98.0K | $91.0K | $236.0K | $241.0K | $255.0K | · | $2M | $573.0K | $449.0K | · | $4M | |
| Current Assets | $145M | $142M | $163M | $144M | $137M | $133M | $148M | $157M | $138M | $143M | · | $125M | $119M | $112M | · | $122M | |
| PP&E (Net) | $103.0K | $124.0K | $187.0K | $305.0K | $388.0K | $474.0K | $515.0K | $601.0K | $680.0K | $757.0K | · | $907.0K | $977.0K | $1M | · | $1M | |
| PP&E (Gross) | $3M | $3M | $5M | $7M | $8M | $8M | $8M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Accum. Depreciation | $3M | $3M | $5M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | $7M | |
| Intangibles | · | · | $41M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $193M | $193M | $216M | $203M | $195M | $196M | $213M | $221M | $205M | $214M | · | $204M | $200M | $196M | · | $199M | |
| Accounts Payable | $3M | $8M | $5M | $6M | $5M | $6M | $6M | $8M | $14M | $9M | · | $5M | $8M | $9M | · | $15M | |
| Accrued Liabilities | $45M | $38M | $50M | $37M | $32M | $27M | $37M | $51M | $39M | $38M | · | $34M | $35M | $34M | · | $40M | |
| Current Liabilities | $50M | $60M | $81M | $83M | $79M | $87M | $96M | $110M | $104M | $98M | · | $67M | $60M | $48M | · | $60M | |
| Capital Leases | $4M | $5M | $5M | $5M | $0 | $0 | $1M | $3M | $4M | $6M | · | $8M | $10M | $11M | · | $13M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $121.0K | $121.0K | $121.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $54M | $64M | $86M | $88M | $90M | $99M | $121M | $150M | $156M | $163M | · | $165M | $170M | $170M | · | $177M | |
| Long-term Debt | $0 | $11M | $23M | $34M | $45M | $57M | $67M | $79M | $91M | $102M | · | $102M | $102M | $102M | · | $102M | |
| Total Debt | $0 | $11M | · | $34M | $45M | · | · | $78M | $89M | $100M | · | $99M | $99M | $99M | · | $98M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | · | $5.0K | $5.0K | $5.0K | · | $5.0K | |
| Retained Earnings | $-1.28B | $-1.29B | $-1.28B | $-1.30B | $-1.31B | $-1.31B | $-1.31B | $-1.33B | $-1.35B | $-1.35B | · | $-1.36B | $-1.36B | $-1.37B | · | $-1.36B | |
| AOCI | $-45.0K | $-31.0K | $36.0K | $19.0K | $-14.0K | $-11.0K | $6.0K | $26.0K | $-32.0K | $-26.0K | · | $-4.0K | $-6.0K | · | · | $0 | |
| Stockholders' Equity | $139M | $128M | $130M | $115M | $105M | $97M | $92M | $71M | $49M | $51M | $53M | $39M | $30M | $26M | $22M | $22M | |
| Liabilities + Equity | $193M | $193M | $216M | $203M | $195M | $196M | $213M | $221M | $205M | $214M | · | $204M | $200M | $196M | · | $199M | |
| Shares Outstanding | 51,102,687 | 50,879,204 | 50,408,023 | 50,384,274 | 49,892,725 | 49,615,174 | 49,105,834 | 49,067,348 | 48,460,120 | 48,214,663 | 47,646,787 | 47,542,790 | 46,947,153 | 46,663,599 | 46,345,660 | 45,608,814 |
キャッシュフロー 9
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $800.0K | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $2M | $15M | $14M | $10M | $14M | $4M | $16M | $11M | $1M | $11M | $10M | $11M | $3M | $3M | $8M | $17M | |
| CapEx | $0 | $0 | $-36.0K | $26.0K | $20.0K | $61.0K | $16.0K | $20.0K | $20.0K | $0 | $45.0K | $27.0K | · | · | $0 | $0 | |
| Investing Cash Flow | $8M | $2M | $-27M | $506.0K | $-11M | $2M | $-2M | $259.0K | $703.0K | $-19M | $-8M | $11M | $-5M | $-17M | $-12M | $8M | |
| Financing Cash Flow | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $0 | $0 | $0 | $0 | $0 | $2M | $-53.0K | |
| Net Change in Cash | $-2M | $7M | $-24M | $-1M | $-8M | $-6M | $2M | $114.0K | $-10M | $-8M | $2M | $22M | $-1M | $-15M | $-2M | $25M | |
| Free Cash Flow | · | $15M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.4% | -8.5% | · | 17.6% | 12.7% | · | · | 27.4% | -4.6% | -5.2% | · | 15.3% | 9.0% | 8.3% | · | 4.2% | |
| Net Margin | 14.5% | -8.4% | · | 16.2% | 11.2% | · | · | 25.2% | -9.6% | -11.0% | · | 10.3% | 3.9% | 2.6% | · | -0.63% | |
| Pretax Margin | 14.6% | -7.6% | · | 17.0% | 11.8% | · | · | 25.6% | -8.8% | -10.5% | · | 10.7% | 4.2% | 2.9% | · | -0.51% | |
| EBITDA Margin | 13.4% | -8.5% | · | 17.6% | 12.7% | · | · | 27.4% | -4.6% | -5.2% | · | 15.3% | 9.0% | 8.3% | · | 4.2% | |
| ROA | 4.2% | -1.9% | · | 4.2% | 2.9% | · | · | 9.6% | -2.2% | -2.4% | · | 2.9% | 1.1% | 0.71% | · | -0.17% | |
| ROE | 6.7% | -3.3% | · | 9.5% | 7.6% | · | · | 37.0% | -11.5% | -12.5% | · | 19.0% | 8.5% | 8.5% | · | -6.4% | |
| ROIC | · | · | · | · | · | · | · | 14.6% | -1.7% | -1.6% | · | 6.0% | 3.5% | 3.2% | · | 2.5% |
流動性と支払能力 5
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.4 | · | 1.7 | 1.7 | · | · | 1.4 | 1.3 | 1.5 | · | 1.9 | 2.0 | 2.3 | · | 2.0 | |
| Quick Ratio | 2.6 | 2.1 | · | 1.5 | 1.5 | · | · | 1.4 | 1.2 | 1.3 | · | 1.7 | 1.8 | 2.1 | · | 1.8 | |
| Debt / Equity | 0.0 | 0.1 | · | 0.3 | 0.4 | · | · | 1.1 | 1.8 | 2.0 | · | 2.6 | 3.3 | 3.8 | · | 4.4 | |
| LT Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.1 | · | · | 0.5 | 0.9 | 1.1 | · | 2.0 | 2.9 | 3.8 | · | 4.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -0.7 | · | 2.6 | 1.5 | 1.3 | · | 0.8 |
効率性 3
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.3 | 0.3 | · | · | 0.4 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 1.1 | 1.2 | · | 2.0 | 1.4 | · | · | 7.0 | 1.3 | 2.0 | · | 2.4 | 1.7 | 2.4 | · | 2.0 | |
| Receivables Turnover | 1.9 | 1.7 | · | 1.2 | 1.9 | · | · | 1.9 | 1.6 | 1.6 | · | 2.0 | 1.7 | 1.8 | · | 2.2 |
バリュエーション（TTM） 14
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $208M | $198M | · | $233M | $226M | $217M | · | $228M | $202M | $207M | · | $221M | $224M | $215M | · | $209M | |
| Net Income TTM | $19M | $14M | · | $38M | $25M | $14M | · | $17M | $-1M | $5M | · | $9M | $13M | $7M | · | $-39M | |
| Market Cap | $414M | $325M | · | $268M | $171M | · | · | $125M | $158M | $256M | · | $125M | $166M | $144M | · | $108M | |
| Enterprise Value | $321M | $235M | · | $207M | $120M | · | · | $106M | $150M | $248M | · | $139M | $190M | $172M | · | $128M | |
| P/E | 21.3 | 22.8 | · | 7.0 | 6.9 | 10.6 | · | 7.5 | -163.0 | 53.0 | · | 13.8 | 12.6 | 20.6 | · | -2.4 | |
| P/S | 2.0 | 1.6 | · | 1.1 | 0.8 | · | · | 0.6 | 0.8 | 1.2 | · | 0.6 | 0.7 | 0.7 | · | 0.5 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 1.6 | · | · | 1.8 | 3.3 | 5.0 | · | 3.2 | 5.5 | 5.6 | · | 4.9 | |
| P / Tangible Book | 3.0 | 2.5 | · | 2.3 | 1.6 | 1.5 | · | 1.8 | 3.3 | 5.0 | · | 3.2 | 5.5 | 5.6 | · | 4.9 | |
| P / Cash Flow | · | 21.1 | · | · | · | · | · | · | · | 22.7 | · | · | · | 54.6 | · | · | |
| P / FCF | · | 21.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 42.3 | -61.4 | · | 21.6 | 18.1 | · | · | 4.8 | -68.9 | -108.0 | · | 16.2 | 38.9 | 39.3 | · | 53.5 | |
| EV / FCF | · | 15.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 1.5 | 1.2 | · | 0.9 | 0.5 | · | · | 0.5 | 0.7 | 1.2 | · | 0.6 | 0.8 | 0.8 | · | 0.6 | |
| Earnings Yield | 4.7% | 4.4% | · | 14.3% | 14.6% | 9.5% | · | 13.3% | -0.61% | 1.9% | · | 7.2% | 7.9% | 4.9% | · | -40.9% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $228M | $230M | $236M | $228M | $253M |
| 営業利益率 % | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% |
| 純利益 | $31M | $30M | $22M | $2.0K | $-29M |
| 希薄化後EPS | $0.61 | $0.62 | $0.45 | $0.00 | $-0.72 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 負債資本倍率 | 0.2 | 0.7 | 1.9 | 4.5 | -39.7 |
| 流動比率 | 2.0 | 1.5 | 1.6 | 1.7 | 1.3 |
| クイックレシオ | 1.9 | 1.4 | 1.4 | 1.6 | 1.0 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $42M | $39M | $27M | $-16M | $21M |
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
📊
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 173 提出者 · $239.8M合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 28 (+2 前期比) | 15 (-2 前期比) | 56 (+1 前期比) | 47 (+7 前期比) | +4.1M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | $33,504,835 | 4,131,299 | 13.97% | 株式数 |
| VANGUARD GROUP INC | $21,011,306 | 3,531,312 | 8.76% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $18,815,168 | 2,319,996 | 7.85% | 株式数 |
| RENAISSANCE TECHNOLOGIES LLC | $14,891,687 | 1,836,213 | 6.21% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $14,887,065 | 1,835,643 | 6.21% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $14,805,608 | 1,825,599 | 6.18% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $11,407,283 | 1,406,570 | 4.76% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $9,618,136 | 1,185,702 | 4.01% | 株式数 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $9,113,880 | 1,123,783 | 3.80% | 株式数 |
| STATE STREET CORP | $7,722,058 | 952,165 | 3.22% | 株式数 |
| KENNEDY CAPITAL MANAGEMENT LLC | $7,082,082 | 873,253 | 2.95% | 株式数 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $6,420,006 | 791,616 | 2.68% | 株式数 |
| RITHOLTZ WEALTH MANAGEMENT | $6,080,862 | 749,798 | 2.54% | 株式数 |
| Connor, Clark & Lunn Investment Management Ltd. | $5,214,292 | 642,946 | 2.17% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $4,884,166 | 602,240 | 2.04% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $4,318,170 | 532,450 | 1.80% | 株式数 |
| GLOBEFLEX CAPITAL L P | $3,104,565 | 382,807 | 1.29% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2,506,850 | 309,106 | 1.05% | 株式数 |
| D. E. Shaw & Co., Inc. | $2,300,377 | 283,647 | 0.96% | 株式数 |
| Russell Investments Group, Ltd. | $2,207,323 | 272,173 | 0.92% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $2,182,158 | 269,070 | 0.91% | 株式数 |
| FEDERATED HERMES, INC. | $2,033,712 | 250,766 | 0.85% | 株式数 |
| Empowered Funds, LLC | $1,786,763 | 220,316 | 0.75% | 株式数 |
| PANAGORA ASSET MANAGEMENT INC | $1,764,290 | 217,545 | 0.74% | 株式数 |
| GOLDMAN SACHS GROUP INC | $1,758,256 | 216,801 | 0.73% | 株式数 |
| FMR LLC | $1,708,274 | 210,638 | 0.71% | 株式数 |
| PRUDENTIAL FINANCIAL INC | $1,600,095 | 197,299 | 0.67% | 株式数 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1,526,562 | 188,232 | 0.64% | 株式数 |
| Prospera Financial Services Inc | $1,287,530 | 158,762 | 0.54% | 株式数 |
| Haven Private, LLC | $1,203,913 | 148,448 | 0.50% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $1,140,161 | 140,587 | 0.48% | 株式数 |
| BlackRock, Inc. | $1,134,784 | 139,924 | 0.47% | 株式数 |
| FIRST TRUST ADVISORS LP | $1,055,970 | 130,206 | 0.44% | 株式数 |
| Bank of New York Mellon Corp | $1,048,964 | 129,342 | 0.44% | 株式数 |
| Round Rock Advisors LLC | $1,045,476 | 128,912 | 0.44% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,040,051 | 128,243 | 0.43% | 株式数 |
| STRS OHIO | $686,106 | 84,600 | 0.29% | 株式数 |
| CANADA PENSION PLAN INVESTMENT BOARD | $596,085 | 73,500 | 0.25% | 株式数 |
| Trexquant Investment LP | $585,729 | 72,223 | 0.24% | 株式数 |
| Vise Technologies, Inc. | $584,163 | 72,030 | 0.24% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $520,662 | 64,200 | 0.22% | コールオプション |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $497,000 | 61,255 | 0.21% | 株式数 |
| OpenArc Corporate Advisory, LLC | $482,472 | 59,491 | 0.20% | 株式数 |
| RHUMBLINE ADVISERS | $466,397 | 57,510 | 0.19% | 株式数 |
| TWO SIGMA ADVISERS, LP | $423,045 | 71,100 | 0.18% | 株式数 |
| D'Orazio & Associates, Inc. | $394,795 | 48,680 | 0.16% | 株式数 |
| Vanguard Global Advisers, LLC | $375,225 | 46,267 | 0.16% | 株式数 |
| DEUTSCHE BANK AG\ | $350,287 | 43,192 | 0.15% | 株式数 |
| Man Group plc | $336,614 | 41,506 | 0.14% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $333,240 | 41,090 | 0.14% | 株式数 |
| WINTON GROUP Ltd | $328,528 | 40,509 | 0.14% | 株式数 |
| XTX Topco Ltd | $326,801 | 40,296 | 0.14% | 株式数 |
| State of Wyoming | $323,046 | 39,833 | 0.13% | 株式数 |
| WELLS FARGO & COMPANY/MN | $304,977 | 37,605 | 0.13% | 株式数 |
| EntryPoint Capital, LLC | $303,200 | 37,386 | 0.13% | 株式数 |
| Baron Wealth Management LLC | $294,977 | 36,372 | 0.12% | 株式数 |
| Creative Planning | $289,827 | 35,737 | 0.12% | 株式数 |
| LPL Financial LLC | $280,095 | 34,537 | 0.12% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $279,673 | 34,485 | 0.12% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $257,468 | 31,747 | 0.11% | 株式数 |
| Kathmere Capital Management, LLC | $252,805 | 31,172 | 0.11% | 株式数 |
| FRANKLIN RESOURCES INC | $242,165 | 29,860 | 0.10% | 株式数 |
| ENVESTNET ASSET MANAGEMENT INC | $236,731 | 29,190 | 0.10% | 株式数 |
| Y-Intercept (Hong Kong) Ltd | $212,660 | 26,222 | 0.09% | 株式数 |
| MARTINGALE ASSET MANAGEMENT L P | $205,703 | 25,364 | 0.09% | 株式数 |
| Metis Global Partners, LLC | $204,891 | 25,264 | 0.09% | 株式数 |
| MetLife Investment Management, LLC | $201,720 | 24,873 | 0.08% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $195,451 | 24,100 | 0.08% | プットオプション |
| C2C Wealth Management, LLC | $191,558 | 23,620 | 0.08% | 株式数 |
| Nuveen, LLC | $187,982 | 23,179 | 0.08% | 株式数 |
| PRELUDE CAPITAL MANAGEMENT, LLC | $174,754 | 21,548 | 0.07% | 株式数 |
| One Wealth Advisors, LLC | $170,951 | 21,079 | 0.07% | 株式数 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $165,306 | 20,383 | 0.07% | 株式数 |
| CITIGROUP INC | $154,990 | 19,111 | 0.06% | 株式数 |
| BAILARD, INC. | $146,791 | 18,100 | 0.06% | 株式数 |
| Invesco Ltd. | $142,493 | 17,570 | 0.06% | 株式数 |
| JANE STREET GROUP, LLC | $141,925 | 17,500 | 0.06% | コールオプション |
| Spark Investment Management LLC | $137,870 | 17,000 | 0.06% | 株式数 |
| MORGAN STANLEY | $137,416 | 16,944 | 0.06% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $136,490 | 21,360 | 0.06% | 株式数 |
| Brandywine Global Investment Management, LLC | $129,710 | 21,800 | 0.05% | 株式数 |
| Police & Firemen's Retirement System of New Jersey | $127,481 | 15,719 | 0.05% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $125,510 | 15,476 | 0.05% | 株式数 |
| Lido Advisors, LLC | $122,015 | 15,045 | 0.05% | 株式数 |
| Mariner, LLC | $120,593 | 14,869 | 0.05% | 株式数 |
| Caprock Group, LLC | $112,421 | 13,862 | 0.05% | 株式数 |
| PERKINS CAPITAL MANAGEMENT INC | $108,674 | 13,400 | 0.05% | 株式数 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $107,960 | 13,312 | 0.05% | 株式数 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $105,624 | 13,203 | 0.04% | 株式数 |
| UBS Group AG | $99,923 | 12,321 | 0.04% | 株式数 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $97,774 | 12,056 | 0.04% | 株式数 |
| CWM, LLC | $97,531 | 15,263 | 0.04% | 株式数 |
| R Squared Ltd | $97,247 | 11,991 | 0.04% | 株式数 |
| Abel Hall, LLC | $93,427 | 11,520 | 0.04% | 株式数 |
| IEQ CAPITAL, LLC | $86,542 | 10,671 | 0.04% | 株式数 |
| Williams & Novak, LLC | $85,066 | 10,489 | 0.04% | 株式数 |
| Vanguard Personalized Indexing Management, LLC | $84,409 | 10,408 | 0.04% | 株式数 |
| Ethic Inc. | $83,290 | 10,270 | 0.03% | 株式数 |
| AQR CAPITAL MANAGEMENT LLC | $83,136 | 10,251 | 0.03% | 株式数 |
| INTECH INVESTMENT MANAGEMENT LLC | $82,803 | 10,210 | 0.03% | 株式数 |
企業インサイダー 24 人のインサイダー · 10人の役員 · 12人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Alan H Auerbach | President and CEO | 2026年7月6日 S | 7,261,671 | 0 | 1 | $-363,919 |
| Maximo F Nougues | Chief Financial Officer | 2026年7月6日 S | 230,637 | 0 | 1 | $-77,528 |
| Douglas M Hunt | The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | 2026年7月6日 S | 196,841 | 0 | 1 | $-69,880 |
| Alvin F Wong | Chief Scientific Officer | 2021年6月17日 A | — | 0 | 0 | $0 |
| Richard Paul Bryce | Title of Reporting Person: Chief Medical and Scientific Officer | 2021年4月5日 S | 121,662 | 0 | 0 | $0 |
| Jeffrey Jerome Ludwig | Chief Commercial Officer | 2021年2月17日 A | 36,069 | 0 | 0 | $0 |
| Steven Lo | Chief Commercial Officer | 2019年7月22日 S | 19,557 | 0 | 0 | $0 |
| Charles R Eyler | Title of Reporting Person: Senior Vice President, Finance and Administration and Treasurer | 2019年2月4日 S | 31,957 | 0 | 0 | $0 |
| Robert Charnas | The Reporting Person is the Senior Vice President of Regulatory Affairs and Project Management of the Issuer. | 2017年2月16日 A | 26,453 | 0 | 0 | $0 |
| Richard Benton Phillips | The Reporting Person is the Interim Head of Regulatory Affairs, Quality Assurance and Pharmacovigilance of the Issuer. | 2016年4月15日 A | — | 0 | 0 | $0 |
| Brian M Stuglik | 取締役 | 2026年6月12日 S | 113,858 | 0 | 1 | $-58,320 |
| Allison Dorval | 取締役 | 2026年6月12日 S | 90,780 | 0 | 1 | $-83,592 |
| Adrian Senderowicz | 取締役 | 2026年6月12日 S | 27,000 | 0 | 1 | $-194,400 |
| Troy Edward Wilson | 取締役 | 2026年6月12日 S | 59,750 | 0 | 1 | $-77,760 |
| Jay M Moyes | 取締役 | 2026年6月12日 S | 58,322 | 0 | 1 | $-158,840 |
| Alessandra Cesano | 取締役 | 2026年6月11日 A | 68,850 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | 取締役 | 2026年6月11日 A | 81,000 | 0 | 0 | $0 |
| Ann Calby Miller | 取締役 | 2021年6月15日 A | 40,732 | 0 | 0 | $0 |
| Hugh O'Dowd | 取締役 | 2020年6月9日 A | 25,748 | 0 | 0 | $0 |
| Frank Zavrl | 取締役 | 2020年6月9日 A | 50,993 | 0 | 0 | $0 |
| Thomas Malley | 取締役 | 2014年12月15日 A | 156,551 | 0 | 0 | $0 |
| Faraaz Siddiqi | — | 2011年10月4日 D | 0 | 0 | 0 | $0 |
| Kapil Munjal | — | 2011年10月4日 D | 0 | 0 | 0 | $0 |
| Robert Andrew Johnson | — | 2011年10月4日 D | 0 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 7保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Alan H. Auerbach ×6 提出書類 | 2022年12月13日 | — | 初回提出 | — | SEC |
| Kapil Munjal 2) | 2011年10月4日 | — | 初回提出 | — | SEC |
| Faraaz Siddiqi 2) | 2011年10月4日 | — | 初回提出 | — | SEC |
| Robert Johnson 2) | 2011年10月4日 | — | 初回提出 | — | SEC |
| Robert Johnson | 2007年11月21日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2007年11月19日 | — | 初回提出 | — | SEC |
| Faraaz Siddiqi | 2007年11月19日 | — | 初回提出 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 36のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| ROSC · Lattice Strategies Trust | 0.72% | 52,608 NS | 2026年4月30日 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0.46% | 233,908 SH | 2026年8月8日 | 日次 |
| IWC · iShares Trust | 0.08% | 150,797 SH | 2026年8月8日 | 日次 |
| VFQY · VANGUARD WELLINGTON FUND | 0.06% | 34,260 SH | 2026年8月8日 | 日次 |
| AVUV · AMERICAN CENTURY ETF TRUST | 0.05% | 1,924,360 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 55,680 NS | 2026年5月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.03% | 2,746 SH | 2026年8月8日 | 日次 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 95,559 NS | 2026年5月31日 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 32,358 SH | 2026年8月8日 | 日次 |
| IWN · iShares Trust | 0.02% | 356,623 SH | 2026年8月8日 | 日次 |
| BIB · ProShares Trust | 0.02% | 1,879 NS | 2026年5月31日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 55,064 SH | 2026年8月8日 | 日次 |
| IWM · iShares Trust | 0.01% | 1,153,241 SH | 2026年8月8日 | 日次 |
| RSSL · Global X Funds | 0.01% | 19,123 NS | 2026年4月30日 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.01% | 16,014 SH | 2026年8月8日 | 日次 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 254,380 SH | 2026年8月8日 | 日次 |
| DFAS · Dimensional ETF Trust | 0.01% | 166,672 NS | 2026年4月30日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.01% | 156,761 NS | 2026年4月30日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.01% | 82,003 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 2,027 NS | 2026年5月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 3,611 NS | 2026年4月30日 | N-PORT |
| EBI · RBB Fund Trust | 0.01% | 5,394 NS | 2026年5月31日 | N-PORT |
| UWM · ProShares Trust | 0.00% | 1,585 NS | 2026年5月31日 | N-PORT |
| IWO · iShares Trust | 0.00% | 65,370 SH | 2026年8月8日 | 日次 |
| URTY · ProShares Trust | 0.00% | 1,603 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,071 NS | 2026年5月31日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 34,919 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 6,348 NS | 2026年4月30日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 40 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 9,704 NS | 2026年4月30日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 15,090 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 12,376 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 446,899 SH | 2026年8月8日 | 日次 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,343,121 SH | 2026年8月8日 | 日次 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7,680 SH | 2026年8月8日 | 日次 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,979 SH | 2026年8月8日 | 日次 |